Endometrial cancer inhibitor BN83495

• Research type

  Research Study

• Full title

  A Phase II International Multi-Centre randomised Open Label Study of oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women with Advanced or Recurrent Endometrial Cancer.

• IRAS ID

  21422

• Sponsor organisation

  Ipsen Pharma

• Eudract number

  2009-010613-68

• Clinicaltrials.gov Identifier

  NCT00910091

• Research summary

  N/A

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  09/H1008/116

• Date of REC Opinion

  30 Oct 2009

• REC opinion

  Further Information Favourable Opinion